Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05424822 |
|---|---|
| Brief Title: | A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) |
| First Submitted : | June 15, 2022 |
| First Submitted that Met QC Criteria : | June 15, 2022 |
| First Posted : | June 21, 2022 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |